Evaluation of Some Inflammatory Markers in Autism Spectrum Disorders

NCT05803005 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-04-07

No results posted yet for this study

Summary

Evaluate some Inflammatory markers \[IL-6, IL-8, TNF\_alpha\] in children with autism spectrum disorder

Conditions

Interventions

OTHER

inflammatory marker in autism spectrum disorder

Evaluate some Inflammatory markers \[IL-6, IL-8, TNF\_alpha\] in children with autism spectrum disorder

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • gehan kamal, prof. · assiut universtiy

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-09-01
Completion
2024-10-01

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05803005 on ClinicalTrials.gov